Schedule 13G ownership disclosure

ITEOS THERAPEUTICS INC

Common Stock · CUSIP: 46565G104

Event date: 2025-05-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLC

    Shares: 2,656,640.00 · Class: 6.9%

  • Oleg Nodelman

    Shares: 2,656,640.00 · Class: 6.9%

  • EcoR1 Capital Fund Qualified, L.P.

    Shares: 2,490,694.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000314
Form type
SCHEDULE 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
May 08, 2025
Reporting period
May 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub